+121%

est. 2Y upside i

HealthcareSeries B

Enabling better self care with at-home hormone tracking.

Rank

#281

Sector

HealthTech

Est. Liquidity

~4Y

Data Quality

Data: Medium

Inito offers a probability-weighted expected upside of ~121% over 2 years, but high preference overhang (66% of $68M valuation) and likely future funding needs increase downside risk.

Last updated: July 19, 2026

Bull (20%)+292%

Inito achieves 7x exit multiple on projected $40M revenue, driven by IPO window and category leadership in at-home diagnostics, yielding ~$280M exit. Net of 20% dilution, holder sees ~292% upside.

Base (55%)+145%

Exit multiple converges to 4.5x on $40M revenue, yielding ~$180M exit. After 20% dilution, upside ~145%.

Bear (25%)-69%

Exit multiple compresses to 2x due to competitive pressure or market downturn, exit ~$80M. After preference overhang ($45M to preferred) and 20% dilution, common recovers ~-69%.

Est. time to liquidity~4.0 years

Preference Stack Risk

severe

Funding Intensity

66%

Total funding of $45M represents 66% of the $68M valuation, giving preferred stock a significant liquidation preference.

Dilution Risk

high

With estimated runway of ~14 months from Series B, a future raise within 24 months is likely, potentially diluting common holders by 15-25%.

Secondary Liquidity

none

No secondary market activity reported; liquidity likely limited to M&A or IPO.

Questions to Ask at the Interview

Strategic questions based on Inito's data — designed to show you've done your homework.

  • 1

    “How does Inito plan to expand its platform beyond fertility into other hormone diagnostics and what are the regulatory hurdles?”

  • 2

    “What is the customer acquisition cost and lifetime value for the monitor and refill model?”

  • 3

    “How does the company think about employee equity dilution given the recent Series B and future funding needs?”

Community

Valuation Sentiment

Our model estimates +121% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.